Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;7(5):605-12.
doi: 10.1016/S1525-1578(10)60594-6.

An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene

Affiliations

An enhanced polymerase chain reaction assay to detect pre- and full mutation alleles of the fragile X mental retardation 1 gene

Alessandro Saluto et al. J Mol Diagn. 2005 Nov.

Abstract

Several diagnostic strategies have been applied to the detection of FMR1 gene repeat expansions in fragile X syndrome. Here, we report a novel polymerase chain reaction-based strategy using the Expand Long Template PCR System (Roche Diagnostics, Mannheim, Germany) and the osmolyte betaine. Repeat expansions up to approximately 330 CGGs in males and up to at least approximately 160 CGGs in carrier women could be easily visualized on ethidium bromide agarose gels. We also demonstrated that fluorescence analysis of polymerase chain reaction products was a reliable tool to verify the presence of premutation and full mutation alleles both in males and in females. This technique, primarily designed to detect premutation alleles, can be used as a routine first screen for expanded FMR1 alleles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of betaine concentration on the PCR amplification of the CGG repeat region of the FMR1 gene. Three male subjects, carrying 20, 83, and ∼200 CGG repeats, were tested with increasing concentrations of betaine, from 1.3 to 2.2 mol/L. M, 100-bp ladder molecular weight marker; three marker bands of 300, 500, and 1000 bp are indicated.
Figure 2
Figure 2
Detection of PCR products from the amplification of the CGG region of the FMR1 gene. Five microliters of PCR product was loaded per lane: a, samples male; b, female samples. CGG genotype is indicated below each lane. M1, 100-bp ladder molecular weight marker. M2, molecular weight marker Hi-Low DNA Marker (Bionexus, Oakland, CA).
Figure 3
Figure 3
Automated fluorescence analysis of the PCR products for premutation and full mutation subjects. PCR reactions were performed using 1.7 mol/L betaine. Panels 1 and 2, premutation (male) carriers with alleles of 83 and 90 CGG repeats, respectively. Panels 3 to 5, full mutation males; descending array of peaks visible from 240 to 500 bp. Panel 6, full mutation carrier female with 35/>400 CGG repeats; a main offscale peak corresponds to the normal 35-CGG allele, and a set of low-intensity stutter bands is generated by the full mutation. Panel 7, full mutation mosaic male; the profile is similar to that of a full mutation carrier female in panel 6.
Figure 4
Figure 4
PCR fragment length (abscissa) versus number of CGG repeats (ordinate). ▴, data from 18 sequenced male subjects and 10 clones (Table 2). ○, derived from the average size of the stutter bands generated in 17 premutation or full mutation male subjects.

References

    1. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, van Ommen G-JB, Blonden LAJ, Riggins GJ, Chastain JL, Kunst CB, Galjaard H, Caskey CT, Nelson DL, Oostra BA, Warren ST. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905–914. - PubMed
    1. Hagerman PJ, Hagerman RJ. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev. 2004;10:25–30. - PubMed
    1. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Mac Swinney F, Dennis N, Jacobs P, Syrrou M, Georgiou I, Patsalis PC, Giovannucci Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B, Vieri F. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study—preliminary data. Am J Med Genet. 1999;83:322–325. - PMC - PubMed
    1. Murray A. Premature ovarian failure and the FMR1 gene. Semin Reprod Med. 2000;18:59–66. - PubMed
    1. Murray A, Ennis S, Morton N. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet. 2000;67:253–254. ; author reply, 256–258. - PMC - PubMed

Publication types

LinkOut - more resources